---  
layout: startup_page  
title: "Zucara Therapeutics"  
id: "zucara.ca"  
permalink: "/zucaratherapeuticszucara.ca05012025/"  
website: "http://www.zucara.ca/"  
funding_round: "Series B"  
funding_amount: "$25M"  
investors: "The T1D Fund, Sanofi, The Perceptive Xontogeny Venture Fund (PXV Fund I)"  
about: "Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent hypoglycemia in people with Type 1 diabetes and insulin-dependent Type 2 diabetes. ZT-01 is designed to inhibit somatostatin, a pancreatic hormone that impairs the glucagon response to hypoglycemia. The goal is to restore glucagon secretion and prevent hypoglycemia."  
markets: "Healthtech, Biotech, Diabetes, Pharmaceutical"  
hq: "Toronto, Ontario, Canada"  
founded_year: "2015"  
linkedin: "https://www.linkedin.com/company/zucara-therapeutics-inc-/"  
twitter: "https://twitter.com/zucara_ca"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/zucara-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/153094-33"  

date_display: "01-May-2025"  
date: "2025-05-01"

# SEO Optimization  
meta_title: "Zucara Therapeutics - Series B Funding ($25M)"  
meta_description: "Zucara Therapeutics, Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent hypoglycemia in people with Type 1 diabetes and insulin-d..."  
meta_keywords: "Zucara Therapeutics, Healthtech, Biotech, Diabetes, Pharmaceutical, Series B funding"  
canonical_url: "https://startup.projectstartups.com/zucaratherapeuticszucara.ca05012025/"  
---